The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its external research ...

Huang also highlighted the rise of “AI natives” — brand-new companies, some well-known, such as OpenAI and Anthropic, and some still emerging.

FungaBeam releases an informational overview outlining how its nail fungus light device is described in company materials, including technology context, usage expectations, and safety considerations ...

In terms of modeling, Middle Earth was a little easier. Tolkien essentially wanted it to be a mythical version of Earth at ...

For over a hundred years, the specter of a schizophrenia diagnosis has frightened patients and their families. Yet it confers no useful meaning for treatment or prognosis.

Dr. Gloria Stingley launches new website with 60+ patient videos, testimonials, and weekly blogs on minimally invasive ...

What follows is an accounting of what actually happened when intelligence became abundant. Not because the technology underperformed, but because humans are resilient.

The commemoration of the first notable patriot victory of the Revolutionary War held recently at Moores Creek National ...

A 2026 informational report covering how Red Boost describes its smooth muscle marketing claims, male sexual performance ingredient research context, pricing structure, and what consumers should know ...

Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC – an emerging PD biomarker) at baseline with a reduction ...

Interim analysis of Phase 1b clinical study of GT-02287, including biomarker and clinical endpoints, will be presented in oral symposiumCompany ...